Where does Oxford BioMedica (UK) Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Oxford BioMedica (UK) Limited ranks #27,063 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Oxford BioMedica (UK) Limited hold?

Oxford BioMedica (UK) Limited holds 10 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Oxford BioMedica (UK) Limited's Innovation Score?

Oxford BioMedica (UK) Limited has an Innovation Score of 33.8 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Oxford BioMedica (UK) Limited's patent grant rate increasing or decreasing?

Oxford BioMedica (UK) Limited's recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Oxford BioMedica (UK) Limited's patents?

Oxford BioMedica (UK) Limited's patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Oxford BioMedica (UK) Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Oxford BioMedica (UK) Limited

Q: What technology areas does Oxford BioMedica (UK) Limited focus on?

Oxford BioMedica (UK) Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 10 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Oxford ranks #27,063 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#27,063
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.8/100): 15.9
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27063 · Foreign Corporation #27,063 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,063/49,997
PHOTO-FINISH Opla Energy
CPC-NARROW C12N · 7 areas
INNOV-THIN 33.8/100
CLAIMS-RICH 15.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Opla Energy Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Oxford BioMedica (UK) · this assignee

34
Shenzhen Intellifusion · near

34
SMed-TA/TD · near

34
Wein Holding · near

34
Zwipe AS · near

34
3D Lighting… · lowest

7

What this shows Oxford's Innovation Score is 33.8/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Oxford's grants concentrate

Oxford BioMedica (UK) Limited is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Oxford sits between Opla Energy Ltd. and Panasonic Corporation OF North America.

Oxford's three-year grant acceleration

Oxford BioMedica (UK) Limited shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Opla Energy

10
Optibiotix

10
Orlandi

10
Out of Sight Visi…

10
Oxford Instrument…

10
Oxiteno Indústria…

10
Palobiofarma S L

10
Panasonic OF Nort…

10
Oxford Biomedica… ◀

10

What this shows Oxford holds 10 patents at rank #27,054, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Oxford

By rank, the assignees closest to #27,054 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Oxford's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Oxford, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Wein Holding, LLC 34 Zwipe AS 34 SMed-TA/TD, LLC 34 Shenzhen Intellifusion Technologies Co., Ltd. 34

Oxford's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Oxford BioMedica (UK) Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2016	1	10.0%
2017	1	10.0%
2019	2	20.0%
2020	1	10.0%
2022	2	20.0%
2024	1	10.0%
2025partial year	1	10.0%

Which technologies does Oxford BioMedica (UK) Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C07K - Peptides 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C12Y - Enzymes 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#27,063

of 49,997 tracked assignees

Innovation Score

33.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Oxford BioMedica (UK) Limited's patent record in context - here's where to go next.

Oxford BioMedica (UK) Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #27,063 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Oxford BioMedica (UK) Limited against Opla Energy Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.